BACKGROUND
Incretin-based therapies, including conventional glucagon-like peptide-1 receptor agonists (GLP-1RAs) and GLP-1-containing co-agonists, are being repurposed for psychiatric disorders. The breadth and maturity of the randomized pipeline are easily misread.
METHODS
We searched ClinicalTrials.gov on 1 Septemb...
A. Fagiolini, A. Cuomo· Journal of Psychiatric Resea...· 0 citations
ABSTRACT Introduction Acute suicidal ideation in major depressive disorder (MDD) is a psychiatric emergency requiring rapid risk assessment, containment, and treatment. Conventional monoaminergic antidepressants have delayed onset, leaving an interval during which severe depressive distress persists. Intranasal esketam...
M. Pinzi, A. Cuomo, M. B. Rescalli et al.· Expert Review of Neurotherap...· 0 citations
Highlights What are the main findings? ADHD changes across development, shifting from overt hyperactivity and impulsivity in childhood toward inner restlessness, executive dysfunction, disorganization, and impaired self-regulation in adulthood. The recent increase in adult ADHD diagnoses is compatible with several over...
A. Cuomo, M. Pinzi, A. Fagiolini· Brain Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.